Kura
1 products tracked · names used in filings: Kura
Upcoming milestones
No upcoming milestones listed.
Recent milestones
Thu 13 Nov 2025🇺🇸 FDA approval
FDA approves Komzifti (ziftomenib), a new medicine
Kura; NDA220305; New molecular entity, Priority review; capsule · source
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇺🇸 | Komzifti ziftomenib | Approved | 2025-11-13 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.